| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.971 | 0 | 0.971 | Retinoic acid receptor agonist | 0.971 0 DBMET02548 0.882 0.001 DBMET02554 0.882 0.001 DBMET02549 0.938 0.001 DBMET02552 0.938 0.001 DBMET02550 | ||
| 0.915 | 0.001 | 0.915 | Retinoic acid receptor gamma antagonist | 0.915 0.001 DBMET02548 0.799 0.001 DBMET02554 0.799 0.001 DBMET02549 0.838 0.001 DBMET02552 0.838 0.001 DBMET02550 | ||
| 0.909 | 0.001 | 0.909 | Retinoic acid alpha receptor antagonist | 0.909 0.001 DBMET02548 0.792 0.001 DBMET02554 0.792 0.001 DBMET02549 0.845 0.001 DBMET02552 0.845 0.001 DBMET02550 | ||
| 0.901 | 0.001 | 0.901 | Retinoic acid beta receptor agonist | 0.901 0.001 DBMET02548 0.765 0.001 DBMET02554 0.765 0.001 DBMET02549 0.804 0.001 DBMET02552 0.804 0.001 DBMET02550 | ||
| 0.894 | 0.001 | 0.894 | Retinoic acid beta receptor antagonist | 0.894 0.001 DBMET02548 0.71 0.001 DBMET02554 0.71 0.001 DBMET02549 0.793 0.001 DBMET02552 0.793 0.001 DBMET02550 | ||
| 0.893 | 0 | 0.893 | Retinoid X alpha receptor agonist | 0.893 0 DBMET02548 0.465 0.001 DBMET02554 0.465 0.001 DBMET02549 0.594 0.001 DBMET02552 0.594 0.001 DBMET02550 | ||
| 0.891 | 0.001 | 0.891 | ABCA1 expression enhancer | 0.891 0.001 DBMET02548 0.852 0.001 DBMET02554 0.852 0.001 DBMET02549 0.857 0.001 DBMET02552 0.857 0.001 DBMET02550 | ||
| 0.894 | 0.006 | 0.894 | Apoptosis agonist | 0.894 0.006 DBMET02548 0.877 0.008 DBMET02554 0.877 0.008 DBMET02549 0.875 0.008 DBMET02552 0.875 0.008 DBMET02550 | ||
| 0.888 | 0.001 | 0.888 | Retinoic acid receptor antagonist | 0.888 0.001 DBMET02548 0.811 0.001 DBMET02554 0.811 0.001 DBMET02549 0.839 0.001 DBMET02552 0.839 0.001 DBMET02550 | ||
| 0.861 | 0 | 0.861 | Retinoic acid gamma receptor agonist | 0.861 0 DBMET02548 0.679 0.001 DBMET02554 0.679 0.001 DBMET02549 0.714 0.001 DBMET02552 0.714 0.001 DBMET02550 | ||
| 0.835 | 0 | 0.835 | Retinoid X gamma receptor antagonist | 0.835 0 DBMET02548 0.611 0 DBMET02554 0.611 0 DBMET02549 0.689 0 DBMET02552 0.689 0 DBMET02550 | ||
| 0.834 | 0 | 0.834 | Retinoid X receptor agonist | 0.834 0 DBMET02548 0.397 0.001 DBMET02554 0.397 0.001 DBMET02549 0.54 0.001 DBMET02552 0.54 0.001 DBMET02550 | ||
| 0.823 | 0.011 | 0.884 | Transcription factor NF kappa B inhibitor | 0.823 0.011 DBMET02548 0.884 0.007 DBMET02554 0.884 0.007 DBMET02549 0.849 0.01 DBMET02552 0.849 0.01 DBMET02550 | DBMET02549 | |
| 0.806 | 0.001 | 0.806 | Ornithine decarboxylase inhibitor | 0.806 0.001 DBMET02548 0.748 0.001 DBMET02554 0.748 0.001 DBMET02549 0.654 0.001 DBMET02552 0.654 0.001 DBMET02550 | ||
| 0.798 | 0 | 0.798 | Retinoid X beta receptor antagonist | 0.798 0 DBMET02548 0.238 0.001 DBMET02554 0.238 0.001 DBMET02549 0.367 0.001 DBMET02552 0.367 0.001 DBMET02550 | ||
| 0.789 | 0.001 | 0.789 | Retinoic acid alpha receptor agonist | 0.789 0.001 DBMET02548 0.656 0.001 DBMET02554 0.656 0.001 DBMET02549 0.7 0.001 DBMET02552 0.7 0.001 DBMET02550 | ||
| 0.801 | 0.015 | 0.815 | Antiinflammatory | 0.801 0.015 DBMET02548 0.815 0.013 DBMET02554 0.815 0.013 DBMET02549 0.792 0.017 DBMET02552 0.792 0.017 DBMET02550 | DBMET02549 | |
| 0.785 | 0 | 0.785 | Retinoid X beta receptor agonist | 0.785 0 DBMET02548 0.589 0.001 DBMET02554 0.589 0.001 DBMET02549 0.643 0 DBMET02552 0.643 0 DBMET02550 | ||
| 0.779 | 0 | 0.779 | Retinoid X gamma receptor agonist | 0.779 0 DBMET02548 0.591 0.001 DBMET02554 0.591 0.001 DBMET02549 0.647 0 DBMET02552 0.647 0 DBMET02550 | ||
| 0.77 | 0.001 | 0.77 | Keratolytic | 0.77 0.001 DBMET02548 0.671 0.001 DBMET02554 0.671 0.001 DBMET02549 0.743 0.001 DBMET02552 0.743 0.001 DBMET02550 | ||
| 0.739 | 0.005 | 0.769 | Antioxidant | 0.739 0.005 DBMET02548 0.681 0.006 DBMET02554 0.681 0.006 DBMET02549 0.769 0.005 DBMET02552 0.769 0.005 DBMET02550 | DBMET02550 | |
| 0.721 | 0 | 0.721 | Retinoid X receptor antagonist | 0.721 0 DBMET02548 0.21 0.001 DBMET02554 0.21 0.001 DBMET02549 0.366 0.001 DBMET02552 0.366 0.001 DBMET02550 | ||
| 0.708 | 0 | 0.708 | Retinoid X alpha receptor antagonist | 0.708 0 DBMET02548 0.182 0.001 DBMET02554 0.182 0.001 DBMET02549 0.34 0.001 DBMET02552 0.34 0.001 DBMET02550 | ||
| 0.64 | 0.006 | 0.64 | Hypoglycemic | 0.64 0.006 DBMET02548 0.607 0.008 DBMET02554 0.607 0.008 DBMET02549 0.632 0.007 DBMET02552 0.632 0.007 DBMET02550 | ||
| 0.64 | 0.019 | 0.652 | 15-Lipoxygenase inhibitor | 0.64 0.019 DBMET02548 0.348 0.101 DBMET02554 0.348 0.101 DBMET02549 0.652 0.017 DBMET02552 0.652 0.017 DBMET02550 | DBMET02550 | |
| 0.625 | 0.023 | 0.627 | Cyclophilin D inhibitor | 0.625 0.023 DBMET02548 0.615 0.025 DBMET02554 0.615 0.025 DBMET02549 0.627 0.023 DBMET02552 0.627 0.023 DBMET02550 | DBMET02550 | |
| 0.547 | 0.003 | 0.547 | Phospholipase A2 inhibitor | 0.547 0.003 DBMET02548 0.367 0.006 DBMET02554 0.367 0.006 DBMET02549 0.494 0.004 DBMET02552 0.494 0.004 DBMET02550 | ||
| 0.561 | 0.019 | 0.601 | Immunosuppressant | 0.561 0.019 DBMET02548 0.601 0.013 DBMET02554 0.601 0.013 DBMET02549 0.541 0.023 DBMET02552 0.541 0.023 DBMET02550 | DBMET02549 | |
| 0.545 | 0.004 | 0.545 | Aldehyde dehydrogenase inhibitor | 0.545 0.004 DBMET02548 0.34 0.008 DBMET02554 0.34 0.008 DBMET02549 0.423 0.005 DBMET02552 0.423 0.005 DBMET02550 | ||
| 0.532 | 0.001 | 0.532 | Transcription factor AP-1 inhibitor | 0.532 0.001 DBMET02548 0.461 0.002 DBMET02554 0.461 0.002 DBMET02549 0.473 0.002 DBMET02552 0.473 0.002 DBMET02550 | ||
| 0.54 | 0.013 | 0.59 | Free radical scavenger | 0.54 0.013 DBMET02548 0.508 0.015 DBMET02554 0.508 0.015 DBMET02549 0.59 0.009 DBMET02552 0.59 0.009 DBMET02550 | DBMET02550 | |
| 0.533 | 0.014 | 0.571 | Nitric oxide antagonist | 0.533 0.014 DBMET02548 0.571 0.011 DBMET02554 0.571 0.011 DBMET02549 0.483 0.017 DBMET02552 0.483 0.017 DBMET02550 | DBMET02549 | |
| 0.526 | 0.01 | 0.528 | Hypolipemic | 0.526 0.01 DBMET02548 0.516 0.011 DBMET02554 0.516 0.011 DBMET02549 0.528 0.01 DBMET02552 0.528 0.01 DBMET02550 | DBMET02550 | |
| 0.516 | 0.017 | 0.597 | Lipoxygenase inhibitor | 0.516 0.017 DBMET02548 0.303 0.07 DBMET02554 0.303 0.07 DBMET02549 0.597 0.01 DBMET02552 0.597 0.01 DBMET02550 | DBMET02550 | |
| 0.501 | 0.02 | 0.593 | Caspase 3 stimulant | 0.501 0.02 DBMET02548 0.501 0.02 DBMET02554 0.501 0.02 DBMET02549 0.593 0.011 DBMET02552 0.593 0.011 DBMET02550 | DBMET02550 | |
| 0.496 | 0.061 | 0.706 | Caspase 9 stimulant | 0.496 0.061 DBMET02548 0.568 0.041 DBMET02554 0.568 0.041 DBMET02549 0.706 0.023 DBMET02552 0.706 0.023 DBMET02550 | DBMET02550 | |
| 0.458 | 0.054 | 0.501 | Antibacterial | 0.458 0.054 DBMET02548 0.501 0.04 DBMET02554 0.501 0.04 DBMET02549 0.469 0.05 DBMET02552 0.469 0.05 DBMET02550 | DBMET02549 | |
| 0.408 | 0.009 | 0.511 | Lipid peroxidase inhibitor | 0.408 0.009 DBMET02548 0.339 0.014 DBMET02554 0.339 0.014 DBMET02549 0.511 0.005 DBMET02552 0.511 0.005 DBMET02550 | DBMET02550 | |
| 0.435 | 0.045 | 0.52 | Vasodilator, peripheral | 0.435 0.045 DBMET02548 0.52 0.024 DBMET02554 0.52 0.024 DBMET02549 0.452 0.04 DBMET02552 0.452 0.04 DBMET02550 | DBMET02549 | |
| 0.426 | 0.042 | 0.426 | Immunostimulant | 0.426 0.042 DBMET02548 0.425 0.043 DBMET02554 0.425 0.043 DBMET02549 0.388 0.053 DBMET02552 0.388 0.053 DBMET02550 | ||
| 0.421 | 0.065 | 0.487 | Histamine release inhibitor | 0.421 0.065 DBMET02548 0.433 0.059 DBMET02554 0.433 0.059 DBMET02549 0.487 0.033 DBMET02552 0.487 0.033 DBMET02550 | DBMET02550 | |
| 0.358 | 0.002 | 0.361 | Adenylate cyclase stimulant | 0.358 0.002 DBMET02548 0.361 0.002 DBMET02554 0.361 0.002 DBMET02549 0.308 0.003 DBMET02552 0.308 0.003 DBMET02550 | DBMET02549 | |
| 0.371 | 0.026 | 0.434 | DNA synthesis inhibitor | 0.371 0.026 DBMET02548 0.434 0.018 DBMET02554 0.434 0.018 DBMET02549 0.406 0.021 DBMET02552 0.406 0.021 DBMET02550 | DBMET02549 | |
| 0.355 | 0.014 | 0.43 | Interferon gamma antagonist | 0.355 0.014 DBMET02548 0.43 0.009 DBMET02554 0.43 0.009 DBMET02549 0.343 0.015 DBMET02552 0.343 0.015 DBMET02550 | DBMET02549 | |
| 0.342 | 0.047 | 0.42 | Hypoxia-inducible factor 1 alpha inhibitor | 0.342 0.047 DBMET02548 0.42 0.025 DBMET02554 0.42 0.025 DBMET02549 0.415 0.027 DBMET02552 0.415 0.027 DBMET02550 | DBMET02549 | |
| 0.35 | 0.056 | 0.501 | Apoptosis antagonist | 0.35 0.056 DBMET02548 0.501 0.02 DBMET02554 0.501 0.02 DBMET02549 0.387 0.042 DBMET02552 0.387 0.042 DBMET02550 | DBMET02549 | |
| 0.275 | 0.011 | 0.372 | Antineoplastic antibiotic | 0.275 0.011 DBMET02548 0.372 0.006 DBMET02554 0.372 0.006 DBMET02549 0.298 0.01 DBMET02552 0.298 0.01 DBMET02550 | DBMET02549 | |
| 0.277 | 0.018 | 0.277 | Antipruritic | 0.277 0.018 DBMET02548 0.27 0.019 DBMET02554 0.27 0.019 DBMET02549 0.247 0.025 DBMET02552 0.247 0.025 DBMET02550 | ||
| 0.265 | 0.018 | 0.269 | Succinate dehydrogenase inhibitor | 0.265 0.018 DBMET02548 0.225 0.033 DBMET02554 0.225 0.033 DBMET02549 0.269 0.017 DBMET02552 0.269 0.017 DBMET02550 | DBMET02550 | |
| 0.256 | 0.01 | 0.277 | Farnesoid X receptor antagonist | 0.256 0.01 DBMET02548 0.277 0.008 DBMET02554 0.277 0.008 DBMET02549 0.255 0.011 DBMET02552 0.255 0.011 DBMET02550 | DBMET02549 | |
| 0.269 | 0.029 | 0.303 | Neurotrophic factor enhancer | 0.269 0.029 DBMET02548 0.303 0.017 DBMET02554 0.303 0.017 DBMET02549 0.294 0.02 DBMET02552 0.294 0.02 DBMET02550 | DBMET02549 | |
| 0.245 | 0.007 | 0.261 | Arachidonic acid antagonist | 0.245 0.007 DBMET02548 0.261 0.004 DBMET02554 0.261 0.004 DBMET02549 0.258 0.004 DBMET02552 0.258 0.004 DBMET02550 | DBMET02549 | |
| 0.26 | 0.023 | 0.28 | Bone formation stimulant | 0.26 0.023 DBMET02548 0.28 0.02 DBMET02554 0.28 0.02 DBMET02549 0.202 0.035 DBMET02552 0.202 0.035 DBMET02550 | DBMET02549 | |
| 0.254 | 0.017 | 0.341 | Cholesterol synthesis inhibitor | 0.254 0.017 DBMET02548 0.341 0.008 DBMET02554 0.341 0.008 DBMET02549 0.329 0.009 DBMET02552 0.329 0.009 DBMET02550 | DBMET02549 | |
| 0.273 | 0.038 | 0.285 | Hepatoprotectant | 0.273 0.038 DBMET02548 0.272 0.038 DBMET02554 0.272 0.038 DBMET02549 0.285 0.034 DBMET02552 0.285 0.034 DBMET02550 | DBMET02550 | |
| 0.256 | 0.025 | 0.279 | Protein kinase stimulant | 0.256 0.025 DBMET02548 0.279 0.02 DBMET02554 0.279 0.02 DBMET02549 0.238 0.03 DBMET02552 0.238 0.03 DBMET02550 | DBMET02549 | |
| 0.309 | 0.082 | 0.37 | Antithrombotic | 0.309 0.082 DBMET02548 0.342 0.067 DBMET02554 0.342 0.067 DBMET02549 0.37 0.058 DBMET02552 0.37 0.058 DBMET02550 | DBMET02550 | |
| 0.208 | 0.006 | 0.212 | Peroxisome proliferator-activated receptor gamma agonist | 0.208 0.006 DBMET02548 0.163 0.01 DBMET02554 0.163 0.01 DBMET02549 0.212 0.006 DBMET02552 0.212 0.006 DBMET02550 | DBMET02550 | |
| 0.268 | 0.067 | 0.268 | Tumour necrosis factor alpha release inhibitor | 0.268 0.067 DBMET02548 0.217 0.095 DBMET02554 0.217 0.095 DBMET02549 0.199 0.11 DBMET02552 0.199 0.11 DBMET02550 | ||
| 0.261 | 0.067 | 0.276 | Gastrin inhibitor | 0.261 0.067 DBMET02548 0.258 0.07 DBMET02554 0.258 0.07 DBMET02549 0.276 0.052 DBMET02552 0.276 0.052 DBMET02550 | DBMET02550 | |
| 0.212 | 0.024 | 0.26 | DNA polymerase I inhibitor | 0.212 0.024 DBMET02548 0.26 0.015 DBMET02554 0.26 0.015 DBMET02549 0.228 0.021 DBMET02552 0.228 0.021 DBMET02550 | DBMET02549 | |
| 0.224 | 0.038 | 0.228 | Protein-tyrosine phosphatase inhibitor | 0.224 0.038 DBMET02548 0.22 0.04 DBMET02554 0.22 0.04 DBMET02549 0.228 0.037 DBMET02552 0.228 0.037 DBMET02550 | DBMET02550 | |
| 0.232 | 0.056 | 0.232 | Platelet adhesion inhibitor | 0.232 0.056 DBMET02548 0.211 0.066 DBMET02554 0.211 0.066 DBMET02549 0.177 0.084 DBMET02552 0.177 0.084 DBMET02550 | ||
| 0.201 | 0.026 | 0.201 | Alkylator | 0.201 0.026 DBMET02548 0.198 0.027 DBMET02554 0.198 0.027 DBMET02549 0.194 0.028 DBMET02552 0.194 0.028 DBMET02550 | ||
| 0.209 | 0.037 | 0.316 | Melanin inhibitor | 0.209 0.037 DBMET02548 0.316 0.02 DBMET02554 0.316 0.02 DBMET02549 0.22 0.034 DBMET02552 0.22 0.034 DBMET02550 | DBMET02549 | |
| 0.189 | 0.022 | 0.23 | Microtubule formation inhibitor | 0.189 0.022 DBMET02548 0.23 0.014 DBMET02554 0.23 0.014 DBMET02549 0.178 0.026 DBMET02552 0.178 0.026 DBMET02550 | DBMET02549 | |
| 0.191 | 0.032 | 0.21 | Protein-tyrosine phosphatase 1B inhibitor | 0.191 0.032 DBMET02548 0.21 0.026 DBMET02554 0.21 0.026 DBMET02549 0.206 0.027 DBMET02552 0.206 0.027 DBMET02550 | DBMET02549 | |
| 0.168 | 0.018 | 0.241 | Androgen antagonist | 0.168 0.018 DBMET02548 0.241 0.01 DBMET02554 0.241 0.01 DBMET02549 0.184 0.015 DBMET02552 0.184 0.015 DBMET02550 | DBMET02549 | |
| 0.184 | 0.036 | 0.184 | Neurotrophic factor | 0.184 0.036 DBMET02548 0.157 0.053 DBMET02554 0.157 0.053 DBMET02549 0.155 0.055 DBMET02552 0.155 0.055 DBMET02550 | ||
| 0.14 | 0.008 | 0.14 | CDC25B inhibitor | 0.14 0.008 DBMET02548 0.093 0.019 DBMET02554 0.093 0.019 DBMET02549 0.128 0.009 DBMET02552 0.128 0.009 DBMET02550 | ||
| 0.159 | 0.031 | 0.159 | GABA C receptor agonist | 0.159 0.031 DBMET02548 0.112 0.055 DBMET02554 0.112 0.055 DBMET02549 0.136 0.04 DBMET02552 0.136 0.04 DBMET02550 | ||
| 0.132 | 0.004 | 0.132 | Liver X receptor alpha agonist | 0.132 0.004 DBMET02548 0.071 0.008 DBMET02554 0.071 0.008 DBMET02549 0.065 0.01 DBMET02552 0.065 0.01 DBMET02550 | ||
| 0.199 | 0.074 | 0.211 | Insulin sensitizer | 0.199 0.074 DBMET02548 0.193 0.081 DBMET02554 0.193 0.081 DBMET02549 0.211 0.063 DBMET02552 0.211 0.063 DBMET02550 | DBMET02550 | |
| 0.152 | 0.029 | 0.152 | TRPA1 agonist | 0.152 0.029 DBMET02548 0.099 0.09 DBMET02552 0.099 0.09 DBMET02550 | ||
| 0.151 | 0.041 | 0.161 | Ca2+-transporting ATPase inhibitor | 0.151 0.041 DBMET02548 0.161 0.023 DBMET02554 0.161 0.023 DBMET02549 0.148 0.048 DBMET02552 0.148 0.048 DBMET02550 | DBMET02549 | |
| 0.159 | 0.05 | 0.23 | Alpha-N-acetylglucosaminidase inhibitor | 0.159 0.05 DBMET02548 0.23 0.027 DBMET02554 0.23 0.027 DBMET02549 0.123 0.075 DBMET02552 0.123 0.075 DBMET02550 | DBMET02549 | |
| 0.125 | 0.017 | 0.146 | ATPase (Vacuolar H+) inhibitor | 0.125 0.017 DBMET02548 0.146 0.008 DBMET02554 0.146 0.008 DBMET02549 0.131 0.013 DBMET02552 0.131 0.013 DBMET02550 | DBMET02549 | |
| 0.146 | 0.039 | 0.146 | Ferrochelatase inhibitor | 0.146 0.039 DBMET02548 0.088 0.086 DBMET02554 0.088 0.086 DBMET02549 0.104 0.066 DBMET02552 0.104 0.066 DBMET02550 | ||
| 0.109 | 0.006 | 0.109 | Exportin-1 inhibitor | 0.109 0.006 DBMET02548 0.097 0.01 DBMET02554 0.097 0.01 DBMET02549 0.098 0.01 DBMET02552 0.098 0.01 DBMET02550 | ||
| 0.171 | 0.069 | 0.242 | ATPase inhibitor | 0.171 0.069 DBMET02548 0.242 0.016 DBMET02554 0.242 0.016 DBMET02549 0.211 0.029 DBMET02552 0.211 0.029 DBMET02550 | DBMET02549 | |
| 0.142 | 0.047 | 0.142 | Vanilloid 1 agonist | 0.142 0.047 DBMET02548 0.131 0.064 DBMET02554 0.131 0.064 DBMET02549 0.131 0.064 DBMET02552 0.131 0.064 DBMET02550 | ||
| 0.103 | 0.012 | 0.103 | Peroxisome proliferator-activated receptor alpha agonist | 0.103 0.012 DBMET02548 0.064 0.024 DBMET02554 0.064 0.024 DBMET02549 0.088 0.015 DBMET02552 0.088 0.015 DBMET02550 | ||
| 0.111 | 0.022 | 0.118 | Na+ K+ transporting ATPase inhibitor | 0.111 0.022 DBMET02548 0.118 0.017 DBMET02554 0.118 0.017 DBMET02549 0.108 0.025 DBMET02552 0.108 0.025 DBMET02550 | DBMET02549 | |
| 0.09 | 0.003 | 0.09 | Kainate receptor agonist | 0.09 0.003 DBMET02548 0.071 0.004 DBMET02554 0.071 0.004 DBMET02549 0.062 0.006 DBMET02552 0.062 0.006 DBMET02550 | ||
| 0.263 | 0.178 | 0.263 | Transcription factor inhibitor | 0.263 0.178 DBMET02548 | ||
| 0.103 | 0.018 | 0.113 | Prostaglandin EP2 antagonist | 0.103 0.018 DBMET02548 0.112 0.016 DBMET02554 0.112 0.016 DBMET02549 0.113 0.016 DBMET02552 0.113 0.016 DBMET02550 | DBMET02550 | |
| 0.099 | 0.016 | 0.101 | Peroxisome proliferator-activated receptor gamma antagonist | 0.099 0.016 DBMET02548 0.075 0.041 DBMET02554 0.075 0.041 DBMET02549 0.101 0.015 DBMET02552 0.101 0.015 DBMET02550 | DBMET02550 | |
| 0.121 | 0.039 | 0.15 | Anabolic | 0.121 0.039 DBMET02548 0.15 0.018 DBMET02554 0.15 0.018 DBMET02549 0.139 0.024 DBMET02552 0.139 0.024 DBMET02550 | DBMET02549 | |
| 0.122 | 0.045 | 0.169 | Electron transport complex I inhibitor | 0.122 0.045 DBMET02548 0.119 0.049 DBMET02554 0.119 0.049 DBMET02549 0.169 0.013 DBMET02552 0.169 0.013 DBMET02550 | DBMET02550 | |
| 0.122 | 0.052 | 0.163 | Estrogen antagonist | 0.122 0.052 DBMET02548 0.131 0.036 DBMET02554 0.131 0.036 DBMET02549 0.163 0.019 DBMET02552 0.163 0.019 DBMET02550 | DBMET02550 | |
| 0.077 | 0.008 | 0.103 | Pregnane X receptor antagonist | 0.077 0.008 DBMET02548 0.074 0.01 DBMET02554 0.074 0.01 DBMET02549 0.103 0.003 DBMET02552 0.103 0.003 DBMET02550 | DBMET02550 | |
| 0.082 | 0.013 | 0.082 | Aconitate hydratase inhibitor | 0.082 0.013 DBMET02548 0.049 0.039 DBMET02554 0.049 0.039 DBMET02549 0.058 0.027 DBMET02552 0.058 0.027 DBMET02550 | ||
| 0.082 | 0.014 | 0.083 | Heme oxygenase stimulant | 0.082 0.014 DBMET02548 0.076 0.019 DBMET02554 0.076 0.019 DBMET02549 0.083 0.013 DBMET02552 0.083 0.013 DBMET02550 | DBMET02550 | |
| 0.158 | 0.092 | 0.201 | Phospholipase C inhibitor | 0.158 0.092 DBMET02548 0.201 0.043 DBMET02554 0.201 0.043 DBMET02549 0.163 0.082 DBMET02552 0.163 0.082 DBMET02550 | DBMET02549 | |
| 0.072 | 0.007 | 0.072 | Liver X receptor beta agonist | 0.072 0.007 DBMET02548 0.03 0.028 DBMET02554 0.03 0.028 DBMET02549 0.047 0.011 DBMET02552 0.047 0.011 DBMET02550 | ||
| 0.191 | 0.128 | 0.191 | Superoxide dismutase inhibitor | 0.191 0.128 DBMET02548 0.181 0.141 DBMET02554 0.181 0.141 DBMET02549 0.175 0.148 DBMET02552 0.175 0.148 DBMET02550 | ||
| 0.075 | 0.013 | 0.089 | Glucose-6-phosphate translocase inhibitor | 0.075 0.013 DBMET02548 0.082 0.01 DBMET02554 0.082 0.01 DBMET02549 0.089 0.008 DBMET02552 0.089 0.008 DBMET02550 | DBMET02550 | |
| 0.095 | 0.033 | 0.095 | Thioredoxin reductase inhibitor | 0.095 0.033 DBMET02548 0.079 0.065 DBMET02552 0.079 0.065 DBMET02550 | ||
| 0.119 | 0.059 | 0.119 | Alpha 2b adrenoreceptor antagonist | 0.119 0.059 DBMET02548 | ||
| 0.166 | 0.109 | 0.166 | Growth factor agonist | 0.166 0.109 DBMET02548 | ||
| 0.062 | 0.004 | 0.068 | Prostaglandin EP2 agonist | 0.062 0.004 DBMET02548 0.068 0.004 DBMET02554 0.068 0.004 DBMET02549 0.059 0.005 DBMET02552 0.059 0.005 DBMET02550 | DBMET02549 | |
| 0.065 | 0.012 | 0.065 | Collagenase inhibitor | 0.065 0.012 DBMET02548 0.053 0.026 DBMET02554 0.053 0.026 DBMET02549 0.059 0.017 DBMET02552 0.059 0.017 DBMET02550 | ||
| 0.065 | 0.013 | 0.065 | Factor III inhibitor | 0.065 0.013 DBMET02548 0.054 0.026 DBMET02554 0.054 0.026 DBMET02549 0.056 0.023 DBMET02552 0.056 0.023 DBMET02550 | ||
| 0.088 | 0.036 | 0.105 | CDC25A inhibitor | 0.088 0.036 DBMET02548 0.083 0.04 DBMET02554 0.083 0.04 DBMET02549 0.105 0.025 DBMET02552 0.105 0.025 DBMET02550 | DBMET02550 | |
| 0.059 | 0.008 | 0.092 | Prostaglandin agonist | 0.059 0.008 DBMET02548 0.092 0.005 DBMET02554 0.092 0.005 DBMET02549 0.09 0.005 DBMET02552 0.09 0.005 DBMET02550 | DBMET02549 | |
| 0.053 | 0.006 | 0.058 | HMG CoA reductase inhibitor | 0.053 0.006 DBMET02548 0.058 0.005 DBMET02554 0.058 0.005 DBMET02549 0.052 0.006 DBMET02552 0.052 0.006 DBMET02550 | DBMET02549 | |
| 0.107 | 0.061 | 0.17 | Expectorant | 0.107 0.061 DBMET02548 0.17 0.028 DBMET02554 0.17 0.028 DBMET02549 0.135 0.042 DBMET02552 0.135 0.042 DBMET02550 | DBMET02549 | |
| 0.068 | 0.022 | 0.072 | Antimetabolite | 0.068 0.022 DBMET02548 0.072 0.021 DBMET02554 0.072 0.021 DBMET02549 0.042 0.038 DBMET02552 0.042 0.038 DBMET02550 | DBMET02549 | |
| 0.083 | 0.039 | 0.121 | Phosphofructokinase-1 inhibitor | 0.083 0.039 DBMET02548 0.121 0.025 DBMET02554 0.121 0.025 DBMET02549 0.078 0.042 DBMET02552 0.078 0.042 DBMET02550 | DBMET02549 | |
| 0.21 | 0.173 | 0.21 | Vasodilator, coronary | 0.21 0.173 DBMET02548 0.194 0.188 DBMET02554 0.194 0.188 DBMET02549 | ||
| 0.089 | 0.052 | 0.096 | Transcription factor NF kappa B stimulant | 0.089 0.052 DBMET02548 0.096 0.044 DBMET02554 0.096 0.044 DBMET02549 0.081 0.067 DBMET02552 0.081 0.067 DBMET02550 | DBMET02549 | |
| 0.094 | 0.059 | 0.094 | Uric acid excretion stimulant | 0.094 0.059 DBMET02548 0.084 0.074 DBMET02552 0.084 0.074 DBMET02550 | ||
| 0.062 | 0.026 | 0.063 | Leukotriene B4 antagonist | 0.062 0.026 DBMET02548 0.063 0.025 DBMET02554 0.063 0.025 DBMET02549 0.06 0.027 DBMET02552 0.06 0.027 DBMET02550 | DBMET02549 | |
| 0.108 | 0.074 | 0.108 | Photosensitizer | 0.108 0.074 DBMET02548 | ||
| 0.048 | 0.017 | 0.048 | Membrane dipeptidase inhibitor | 0.048 0.017 DBMET02548 0.042 0.023 DBMET02552 0.042 0.023 DBMET02550 | ||
| 0.045 | 0.016 | 0.057 | Fumarate hydratase inhibitor | 0.045 0.016 DBMET02548 0.057 0.011 DBMET02554 0.057 0.011 DBMET02549 0.038 0.021 DBMET02552 0.038 0.021 DBMET02550 | DBMET02549 | |
| 0.036 | 0.008 | 0.051 | Prostaglandin E2 agonist | 0.036 0.008 DBMET02548 0.051 0.005 DBMET02554 0.051 0.005 DBMET02549 0.044 0.006 DBMET02552 0.044 0.006 DBMET02550 | DBMET02549 | |
| 0.034 | 0.006 | 0.058 | Prostaglandin EP4 agonist | 0.034 0.006 DBMET02548 0.058 0.005 DBMET02554 0.058 0.005 DBMET02549 0.051 0.005 DBMET02552 0.051 0.005 DBMET02550 | DBMET02549 | |
| 0.046 | 0.02 | 0.077 | 5-Alpha-reductase inhibitor | 0.046 0.02 DBMET02548 0.077 0.013 DBMET02552 0.077 0.013 DBMET02550 | DBMET02550 | |
| 0.131 | 0.106 | 0.221 | Growth hormone agonist | 0.131 0.106 DBMET02548 0.221 0.051 DBMET02554 0.221 0.051 DBMET02549 0.14 0.095 DBMET02552 0.14 0.095 DBMET02550 | DBMET02549 | |
| 0.126 | 0.103 | 0.202 | NOS3 expression enhancer | 0.126 0.103 DBMET02548 0.16 0.063 DBMET02554 0.16 0.063 DBMET02549 0.202 0.04 DBMET02552 0.202 0.04 DBMET02550 | DBMET02550 | |
| 0.029 | 0.008 | 0.064 | Vitamin D receptor antagonist | 0.029 0.008 DBMET02548 0.064 0.004 DBMET02554 0.064 0.004 DBMET02549 0.022 0.016 DBMET02552 0.022 0.016 DBMET02550 | DBMET02549 | |
| 0.057 | 0.035 | 0.058 | Adenine nucleotide translocase inhibitor | 0.057 0.035 DBMET02548 0.058 0.032 DBMET02554 0.058 0.032 DBMET02549 0.054 0.044 DBMET02552 0.054 0.044 DBMET02550 | DBMET02549 | |
| 0.146 | 0.125 | 0.183 | Angiogenesis stimulant | 0.146 0.125 DBMET02548 0.183 0.103 DBMET02554 0.183 0.103 DBMET02549 | DBMET02549 | |
| 0.05 | 0.029 | 0.062 | Glucose-6-phosphate isomerase inhibitor | 0.05 0.029 DBMET02548 0.062 0.017 DBMET02554 0.062 0.017 DBMET02549 0.047 0.035 DBMET02552 0.047 0.035 DBMET02550 | DBMET02549 | |
| 0.037 | 0.016 | 0.037 | Prostaglandin EP3 antagonist | 0.037 0.016 DBMET02548 0.028 0.024 DBMET02554 0.028 0.024 DBMET02549 0.033 0.019 DBMET02552 0.033 0.019 DBMET02550 | ||
| 0.025 | 0.004 | 0.035 | Vitamin D receptor agonist | 0.025 0.004 DBMET02548 0.035 0.003 DBMET02554 0.035 0.003 DBMET02549 0.018 0.008 DBMET02552 0.018 0.008 DBMET02550 | DBMET02549 | |
| 0.185 | 0.165 | 0.19 | Tyrosine 3 hydroxylase inhibitor | 0.185 0.165 DBMET02548 0.19 0.154 DBMET02552 0.19 0.154 DBMET02550 | DBMET02550 | |
| 0.094 | 0.075 | 0.131 | Estrogen receptor beta antagonist | 0.094 0.075 DBMET02548 0.097 0.071 DBMET02554 0.097 0.071 DBMET02549 0.131 0.022 DBMET02552 0.131 0.022 DBMET02550 | DBMET02550 | |
| 0.087 | 0.069 | 0.087 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.087 0.069 DBMET02548 | ||
| 0.075 | 0.057 | 0.093 | Estrogen receptor alpha antagonist | 0.075 0.057 DBMET02548 0.087 0.038 DBMET02554 0.087 0.038 DBMET02549 0.093 0.033 DBMET02552 0.093 0.033 DBMET02550 | DBMET02550 | |
| 0.063 | 0.047 | 0.066 | Leukotriene antagonist | 0.063 0.047 DBMET02548 0.065 0.044 DBMET02554 0.065 0.044 DBMET02549 0.066 0.044 DBMET02552 0.066 0.044 DBMET02550 | DBMET02550 | |
| 0.18 | 0.164 | 0.18 | Transcription factor STAT3 inhibitor | 0.18 0.164 DBMET02548 | ||
| 0.143 | 0.128 | 0.155 | P-glycoprotein inhibitor | 0.143 0.128 DBMET02548 0.148 0.121 DBMET02554 0.148 0.121 DBMET02549 0.155 0.11 DBMET02552 0.155 0.11 DBMET02550 | DBMET02550 | |
| 0.036 | 0.021 | 0.036 | Tubulin agonist | 0.036 0.021 DBMET02548 0.035 0.022 DBMET02554 0.035 0.022 DBMET02549 | ||
| 0.083 | 0.071 | 0.094 | Aminoacyl-tRNA synthetase inhibitor | 0.083 0.071 DBMET02548 0.094 0.052 DBMET02554 0.094 0.052 DBMET02549 | DBMET02549 | |
| 0.045 | 0.035 | 0.052 | Microtubule stabilization | 0.045 0.035 DBMET02548 0.052 0.025 DBMET02554 0.052 0.025 DBMET02549 0.045 0.034 DBMET02552 0.045 0.034 DBMET02550 | DBMET02549 | |
| 0.054 | 0.046 | 0.054 | Leukotriene C antagonist | 0.054 0.046 DBMET02548 | ||
| 0.067 | 0.061 | 0.092 | Glycine receptor agonist | 0.067 0.061 DBMET02548 0.092 0.026 DBMET02554 0.092 0.026 DBMET02549 | DBMET02549 | |
| 0.04 | 0.035 | 0.04 | Liver X receptor agonist | 0.04 0.035 DBMET02548 | ||
| 0.031 | 0.026 | 0.031 | Peroxisome proliferator-activated receptor delta agonist | 0.031 0.026 DBMET02548 | ||
| 0.064 | 0.062 | 0.064 | Porphobilinogen synthase inhibitor | 0.064 0.062 DBMET02548 | ||
| 0.054 | 0.052 | 0.064 | Lipocortins synthesis agonist | 0.054 0.052 DBMET02548 0.064 0.029 DBMET02554 0.064 0.029 DBMET02549 0.062 0.033 DBMET02552 0.062 0.033 DBMET02550 | DBMET02549 | |
| 0.206 | 0.205 | 0.251 | Calcium channel activator | 0.206 0.205 DBMET02548 0.251 0.146 DBMET02554 0.251 0.146 DBMET02549 | DBMET02549 | |
| 0.065 | 0.065 | 0.075 | Glutamate dehydrogenase inhibitor | 0.075 0.049 DBMET02554 0.075 0.049 DBMET02549 | DBMET02549 | |
| 0.016 | 0.017 | 0.023 | Peroxisome proliferator-activated receptor alpha antagonist | 0.023 0.014 DBMET02552 0.023 0.014 DBMET02550 | DBMET02550 | |
| 0.003 | 0.004 | 0.005 | Vitamin D-like | 0.005 0.002 DBMET02554 0.005 0.002 DBMET02549 | DBMET02549 | |
| 0.079 | 0.082 | 0.132 | 5-Lipoxygenase inhibitor | 0.132 0.045 DBMET02552 0.132 0.045 DBMET02550 | DBMET02550 | |
| 0.02 | 0.025 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.026 0.009 DBMET02554 0.026 0.009 DBMET02549 | DBMET02549 | |
| 0.049 | 0.055 | 0.058 | Biliverdin reductase inhibitor | 0.058 0.043 DBMET02554 0.058 0.043 DBMET02549 | DBMET02549 | |
| 0.082 | 0.089 | 0.138 | Monophenol monooxygenase inhibitor | 0.09 0.083 DBMET02554 0.09 0.083 DBMET02549 0.138 0.052 DBMET02552 0.138 0.052 DBMET02550 | DBMET02550 | |
| 0.04 | 0.048 | 0.068 | Parathyroid hormone antagonist | 0.068 0.008 DBMET02554 0.068 0.008 DBMET02549 | DBMET02549 | |
| 0.176 | 0.188 | 0.331 | Cholesterol antagonist | 0.271 0.111 DBMET02554 0.271 0.111 DBMET02549 0.331 0.073 DBMET02552 0.331 0.073 DBMET02550 | DBMET02550 | |
| 0.051 | 0.066 | 0.059 | Prostaglandin F2 alpha antagonist | 0.059 0.048 DBMET02554 0.059 0.048 DBMET02549 | DBMET02549 | |
| 0.037 | 0.052 | 0.058 | Adenylate cyclase 1 inhibitor | 0.058 0.019 DBMET02554 0.058 0.019 DBMET02549 | DBMET02549 | |
| 0.081 | 0.097 | 0.09 | Bile acid receptor antagonist | 0.09 0.073 DBMET02554 0.09 0.073 DBMET02549 | DBMET02549 | |
| 0.107 | 0.123 | 0.115 | Papain-like protease (SARS coronavirus) inhibitor | 0.115 0.097 DBMET02554 0.115 0.097 DBMET02549 0.111 0.107 DBMET02552 0.111 0.107 DBMET02550 | DBMET02549 | |
| 0.012 | 0.03 | 0.017 | Telomerase stimulant | 0.017 0.011 DBMET02554 0.017 0.011 DBMET02549 | DBMET02549 | |
| 0.084 | 0.104 | 0.108 | Toll-Like receptor 4 antagonist | 0.105 0.062 DBMET02554 0.105 0.062 DBMET02549 0.108 0.057 DBMET02552 0.108 0.057 DBMET02550 | DBMET02550 | |
| 0.083 | 0.107 | 0.125 | Mucolytic | 0.125 0.05 DBMET02554 0.125 0.05 DBMET02549 0.113 0.062 DBMET02552 0.113 0.062 DBMET02550 | DBMET02549 | |
| 0.069 | 0.103 | 0.079 | Triose-phosphate isomerase inhibitor | 0.079 0.077 DBMET02554 0.079 0.077 DBMET02549 | DBMET02549 | |
| 0.028 | 0.064 | 0.048 | Thromboxane A2 antagonist | 0.048 0.038 DBMET02552 0.048 0.038 DBMET02550 | DBMET02550 | |
| 0.079 | 0.119 | 0.096 | Adenylate kinase inhibitor | 0.096 0.075 DBMET02554 0.096 0.075 DBMET02549 | DBMET02549 | |
| 0.03 | 0.07 | 0.052 | Aldose reductase inhibitor | 0.052 0.037 DBMET02552 0.052 0.037 DBMET02550 | DBMET02550 | |
| 0.081 | 0.12 | 0.115 | Amylase inhibitor | 0.115 0.085 DBMET02554 0.115 0.085 DBMET02549 | DBMET02549 | |
| 0.152 | 0.194 | 0.166 | RNA-directed DNA polymerase inhibitor | 0.166 0.161 DBMET02554 0.166 0.161 DBMET02549 | DBMET02549 | |
| 0.031 | 0.074 | 0.062 | Protein 50S ribosomal subunit inhibitor | 0.062 0.029 DBMET02554 0.062 0.029 DBMET02549 | DBMET02549 | |
| 0.03 | 0.074 | 0.048 | Thromboxane antagonist | 0.048 0.044 DBMET02552 0.048 0.044 DBMET02550 | DBMET02550 | |
| 0.126 | 0.175 | 0.179 | Platelet antagonist | 0.179 0.118 DBMET02552 0.179 0.118 DBMET02550 | DBMET02550 | |
| 0.117 | 0.174 | 0.21 | Lipocortins synthesis antagonist | 0.196 0.059 DBMET02554 0.196 0.059 DBMET02549 0.21 0.05 DBMET02552 0.21 0.05 DBMET02550 | DBMET02550 | |
| 0.168 | 0.235 | 0.306 | Sodium/bile acid cotransporter inhibitor | 0.306 0.073 DBMET02554 0.306 0.073 DBMET02549 0.222 0.159 DBMET02552 0.222 0.159 DBMET02550 | DBMET02549 | |
| 0.114 | 0.183 | 0.154 | Non-steroidal antiinflammatory agent | 0.154 0.11 DBMET02552 0.154 0.11 DBMET02550 | DBMET02550 | |
| 0.029 | 0.098 | 0.052 | Alcohol oxidase inhibitor | 0.052 0.043 DBMET02554 0.052 0.043 DBMET02549 | DBMET02549 | |
| 0.009 | 0.081 | 0.027 | RNA-directed RNA polymerase stimulant | 0.027 0.023 DBMET02554 0.027 0.023 DBMET02549 | DBMET02549 | |
| 0.143 | 0.216 | 0.23 | Peptidyltransferase inhibitor | 0.23 0.067 DBMET02554 0.23 0.067 DBMET02549 | DBMET02549 | |
| 0.171 | 0.246 | 0.267 | Interleukin 2 agonist | 0.267 0.1 DBMET02554 0.267 0.1 DBMET02549 0.233 0.139 DBMET02552 0.233 0.139 DBMET02550 | DBMET02549 | |
| 0.069 | 0.147 | 0.088 | Interleukin 12 antagonist | 0.088 0.078 DBMET02554 0.088 0.078 DBMET02549 | DBMET02549 | |
| 0.104 | 0.188 | 0.134 | Pregnane X receptor agonist | 0.134 0.087 DBMET02554 0.134 0.087 DBMET02549 0.126 0.111 DBMET02552 0.126 0.111 DBMET02550 | DBMET02549 | |
| 0.047 | 0.141 | 0.077 | Glycine receptor antagonist | 0.077 0.062 DBMET02554 0.077 0.062 DBMET02549 | DBMET02549 | |
| 0.064 | 0.16 | 0.105 | AMP-activated protein kinase stimulant | 0.105 0.064 DBMET02554 0.105 0.064 DBMET02549 | DBMET02549 | |
| 0.053 | 0.155 | 0.079 | Glutathione S-transferase inhibitor | 0.079 0.063 DBMET02552 0.079 0.063 DBMET02550 | DBMET02550 | |
| 0.101 | 0.213 | 0.188 | Interleukin agonist | 0.188 0.132 DBMET02554 0.188 0.132 DBMET02549 | DBMET02549 | |
| 0.009 | 0.173 | 0.022 | CYP24 inhibitor | 0.022 0.017 DBMET02554 0.022 0.017 DBMET02549 | DBMET02549 | |
| 0.111 | 0.326 | 0.277 | Immunomodulator | 0.277 0.095 DBMET02554 0.277 0.095 DBMET02549 | DBMET02549 | |
| 0.05 | 0.289 | 0.099 | Cell adhesion inhibitor | 0.099 0.091 DBMET02552 0.099 0.091 DBMET02550 | DBMET02550 | |
| 0.005 | 0.266 | 0.021 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.021 0.004 DBMET02552 0.021 0.004 DBMET02550 | DBMET02550 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |